Skip to content

Smartphone Based Tele-rehabilitation on Functional Capacity and Sleep Quality Among Coronary Heart Disease Patients.

Effectiveness of Smartphone Based Tele-rehabilitation on Cardiovascular Functional Capacity and Sleep Quality Among Coronary Heart Disease Patients.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06548425
Enrollment
38
Registered
2024-08-12
Start date
2024-06-15
Completion date
2025-01-15
Last updated
2025-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Brief summary

To determine the effectiveness of smartphone based tele-rehabilitation on functional capacity and sleep quality among coronary heart disease patients.

Interventions

OTHERSmart Phone Based Cardiac Telerehabilitation

Smart Phone Based Cardiac Telerehabilitation Frequency:3 sessions per week for 8 weeks Intensity: 40-60 % THR and modified borg scale 9 (very light- 13 (somewhat hard) Time: Approx. 30 Min Type: Aerobic & strength Exercises

OTHERCenter based cardiac Rehabilitation

Center based cardiac Rehabilitation Frequency:3 sessions per week for 8 weeks Intensity: 40-60% THR and modified borg scale 9 (very light- 13 (somewhat hard) Time: Approx. 30 Min Type: Aerobic & strength Exercises

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Both Male & Female * Age 20-69 years * Participants should have a documented diagnosis of CAD, confirmed by a medical professional. * Individuals with a history of myocardial infarction (heart attack), angina, or evidence of significant coronary artery stenosis. * Stable CAD who are not experiencing acute coronary events, such as recent heart attacks or unstable angina.

Exclusion criteria

* Acute illness * Uncontrolled hypertension * Uncontrolled metabolic disease * Bone fracture in the last 6 months * Neurological diseases that limit the ability to ambulate or stand from a chair * MSK disease * Severe cardiovascular complications such as heart failure with reduced ejection fraction, severe arrhythmias. * Patients with unstable conditions or cardiac episodes. * Ejection fraction \< 40%

Design outcomes

Primary

MeasureTime frameDescription
Pittsburgh Sleep Quality Index8 weekThe Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. Only self-rated questions are included in the scoring. The 19 self-rated items are combined to form seven component scores, each of which has a range of 0-3 points. In all cases, a score of 0 indicates no difficulty, while a score of 3 indicates severe difficulty. The PSQI has a high test-retest reliability and a good validity for patients with cardiac patients. Changes from the baseline will be measured.
Duke Activity Status Index8 weekThe Duke Activity Status Index (DASI) is an assessment tool used to evaluate the functional capacity of patients with cardiovascular disease (CVD), such as coronary artery disease, myocardial infarction, and heart failure. In clinical practice, DASI can be used to assess the effects of medical treatments and cardiac rehabilitation as well. Positive responses are summed up to get a total score, which ranges from 0 to 58.2. Higher scores would indicate a higher functional capacity. Changes from the baseline will be measured.
6 Minute walk test8 weeksix-minute walk test as a measure of functional status or fitness Before you begin to walk, the researchers will take a participant's blood pressure, pulse, and oxygen saturation using a pulse oximeter. Participants will get the instructions below. For six minutes, the contestants will walk as far as they can. to a chair or cone at your usual speed, then turn around. and will keep going back and forth for another six minutes. Distance will be measured in meters. Changes from the baseline will be measured.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026